<DOC>
	<DOCNO>NCT01042860</DOCNO>
	<brief_summary>Rationale : Age-related macular degeneration common cause blindness industrialize world . Macular pigment hypothesize protect vision loss disease . Objective : 1 . To study macular pigment optical density raise lutein supplementation . 2 . To study lutein supplementation stop slow decrease visual function . Study design : Randomized , double blind , placebo control intervention study . Study population : Eighty patient early sign age-related macular degeneration Intervention : The intervention group ( 40 subject ) receive 10 mg lutein per day , control group ( 40 subject ) get placebo .</brief_summary>
	<brief_title>The Influence Lutein Supplements Age-related Macular Degeneration</brief_title>
	<detailed_description />
	<mesh_term>Macular Degeneration</mesh_term>
	<criteria>AMD grade 2 3 visual acuity &gt; 0.5 BMI &lt; 30 use lutein supplement smoke diabetes disease interfere lipid absorption eye disease</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>January 2010</verification_date>
	<keyword>macular pigment</keyword>
	<keyword>lutein</keyword>
	<keyword>age-related macular degeneration</keyword>
	<keyword>AMD</keyword>
</DOC>